Cargando…

Frontiers in Bladder Cancer Genomic Research

Most of the etiology studies of bladder cancer focus on genetic changes, mainly including mutation and activation of oncogenes, mutation and inactivation of tumor suppressor genes, and rearrangement or heterozygous deletion of chromosomes. Moreover, bladder cancer is highly heterogeneous mainly due...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi, Sun, Lihui, Guo, Xiangyang, Mo, Na, Zhang, Jinku, Li, Chong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173177/ https://www.ncbi.nlm.nih.gov/pubmed/34094968 http://dx.doi.org/10.3389/fonc.2021.670729

Ejemplares similares

Editorial: New frontiers in “bladder sparing” treatments for high risk NMIBC
por: Hurle, Rodolfo, et al.
Publicado: (2023)

Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field
por: Cheng, Kunming, et al.
Publicado: (2022)

A bibliometric and visualization-based analysis of temozolomide research hotspots and frontier evolution
por: Song, Peng, et al.
Publicado: (2022)

Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment
por: Murphy, Anthony J., et al.
Publicado: (2022)

Global research status and frontiers on microvascular invasion of hepatocellular carcinoma: A bibliometric and visualized analysis
por: He, Tao, et al.
Publicado: (2022)

Frontiers Research Topic: Radiation-Induced Effects and the Immune System
por: Multhoff, Gabriele, et al.
Publicado: (2013)

Current research trends, hotspots, and frontiers of medical nutrition therapy on cancer: a bibliometric analysis
por: Xia, Hongfang, et al.
Publicado: (2023)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021)

Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy
por: Lu, Yilei, et al.
Publicado: (2022)

Bacillus Calmette–Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer
por: Su, Fei, et al.
Publicado: (2022)

Editorial: Glycosylation Changes in Cancer: An Innovative Frontier at the Interface of Cancer and Glycobiology
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2016)

The global research of bladder cancer immunotherapy from 2012 to 2021: A bibliometric analysis
por: Qiu, Qiuqiu, et al.
Publicado: (2022)

Inflammation-related research within the field of bladder cancer: a bibliometric analysis
por: Deng, Zhixuan, et al.
Publicado: (2023)

Editorial: Bladder Cancer – A Cinderella Cancer: Advances and Remaining Research Questions
por: Van Hemelrijck, Mieke, et al.
Publicado: (2020)

Detecting and monitoring bladder cancer with exfoliated cells in urine
por: Li, Nannan, et al.
Publicado: (2022)

Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI
por: Richters, Anke, et al.
Publicado: (2021)

The Roles of Glycans in Bladder Cancer
por: Jian, Yuli, et al.
Publicado: (2020)

Hope and challenge: Precision medicine in bladder cancer
por: Su, Hongwei, et al.
Publicado: (2019)

Deep Learning on Enhanced CT Images Can Predict the Muscular Invasiveness of Bladder Cancer
por: Zhang, Gumuyang, et al.
Publicado: (2021)

Role of NRP1 in Bladder Cancer Pathogenesis and Progression
por: Dong, Yang, et al.
Publicado: (2021)

New Frontiers for the Cytoskeletal Protein LASP1
por: Butt, Elke, et al.
Publicado: (2018)

Current and Future Frontiers of Molecularly Defined Oligodendrogliomas
por: Rincon-Torroella, Jordina, et al.
Publicado: (2022)

Research Progress of circRNAs in Head and Neck Cancers
por: Li, Panchun, et al.
Publicado: (2021)

Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis
por: Deng, Sheng, et al.
Publicado: (2022)

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?
por: Bai, Rilan, et al.
Publicado: (2020)

Carbohydrates, Glycemic Index, and Glycemic Load in Relation to Bladder Cancer Risk
por: Zhu, Hejia, et al.
Publicado: (2020)

Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma
por: Rohatgi, Anjali, et al.
Publicado: (2021)

Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
por: Zhang, Chunyu, et al.
Publicado: (2021)

LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma
por: Liu, Xiang, et al.
Publicado: (2020)

CircRNAs: Emerging Bladder Cancer Biomarkers and Targets
por: Liang, Zhaofeng, et al.
Publicado: (2021)

Propofol Inhibits the Proliferation, Migration, and Stem-like Properties of Bladder Cancer Mainly by Suppressing the Hedgehog Pathway
por: Li, Gang, et al.
Publicado: (2021)

A Benchmark Dataset and Deep Learning-Based Image Reconstruction for Electrical Capacitance Tomography
por: Zheng, Jin, et al.
Publicado: (2018)

Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges
por: Zuppone, Stefania, et al.
Publicado: (2020)

OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts
por: Lin, Jiaxing, et al.
Publicado: (2021)

A deep learning model for drug screening and evaluation in bladder cancer organoids
por: Zhang, Shudi, et al.
Publicado: (2023)

Research Advances on Anti-Cancer Natural Products
por: Guo, Meng, et al.
Publicado: (2022)

Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4
por: Jia, Changxin, et al.
Publicado: (2023)

Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer
por: Xu, Xiaopan, et al.
Publicado: (2021)

Serum metabolites as early detection markers of non-muscle invasive bladder cancer in Chinese patients
por: Zhao, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a2cv4i855trhlg2lvibp8tnhti